Strategic consolidation: The biotechnology business model for the 21st century: Is it time to break from the pack in defining your company’s future?

Nature Biotechnology

Volumn 17, Issue 1s, 1999, Pages BE16-BE17

  Esposito, Robert S ^a   Ostro, Marc J ^b  

^a KPMG Peat Marwick LLP ^*  (United States)

^b KPMG LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CAPITAL; INDUSTRY; INVESTMENT; MARKETING; MODEL; PRIORITY JOURNAL; SHORT SURVEY;

BIOTECHNOLOGY; CAPITAL FINANCING; COMMERCE; INVESTMENTS;

EID: 0033002170     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/4630     Document Type: Article

References (0)